United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-455_47d2acba-fb93-f1a3-e063-6394a90aa13f
- Product NDC
- 43063-455
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020703
- Source listing expiry
- 20271231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 15 TABLET in 1 BOTTLE, PLASTIC (43063-455-15) · 43063-455-15
- 20 TABLET in 1 BOTTLE, PLASTIC (43063-455-20) · 43063-455-20
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-455-30) · 43063-455-30
- 40 TABLET in 1 BOTTLE, PLASTIC (43063-455-40) · 43063-455-40
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-455-60) · 43063-455-60
- 90 TABLET in 1 BOTTLE, PLASTIC (43063-455-90) · 43063-455-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →